Participate in the Coronavirus Vaccine Study
The goal of this study is to determine the safety of the vaccine and measure how strongly it triggers the body’s immune response to COVID-19.
This is a recombinant vaccine, so you will not be exposed to Coronavirus / COVID-19 by taking part in this study.
Participants in this research are reimbursed $2,450 for their time and this clinical trial has been approved by an independent ethics committee.
You must be able to attend 8 outpatient visits at our facility in Brisbane. You are not required to stay overnight at our facility, and there is some flexibility in the dates of the outpatient visits.